Cognizant Technology Solutions Corporation Profile Avatar - Palmy Investing

Cognizant Technology Solutions Corporation

Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally. It operates through four segments: Financial Services; Healthcare;
Information Technology Services
US, Teaneck [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 28% Weak
Profitability n.A. n.A.
Fin. Growth 17% Weak
Leverage & Liquidity 17% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -0.80 41.33 41.67
Graham Fair Price 0.50 25.90 25.77
PEG 315.70 -9.14 2.20
Price/Book -7.42 2.64 2.86
Price/Cash Flow 3789.15 2228.73 57.31
Prices/Earnings -3.50 16.33 16.92
Price/Sales -5.61 7.49 7.94
Price/FCF 3789.15 2228.73 57.31
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -4.61 0.31 0.33
Operating Margin -6.55 0.15 0.16
ROA -1.75 0.03 0.03
ROE 0.04 0.04 -4.06
ROIC 0.04 0.04 -6.57
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.03 -0.09 67.88
Dividends QOQ < 0.005 0.04 3442.83
EBIT QOQ 0.12 -0.07 -45.53
EPS QOQ 0.08 -0.02 -76.79
FCF QOQ -0.13 -0.98 -667.36
Revenue QOQ -0.03 < 0.005 -98.52
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 0.00 0.00 0.00
Days Sales Outstanding (DSO) 72.81 72.26 -0.74
Inventory Turnover 0.00 0.00 0.00
Debt/Capitalization 0.06 0.05 -3.95
Quick Ratio 1.95 2.01 3.51
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 26.45 27.14 2.60
Cash 5.27 4.51 -14.36
Capex -0.16 -0.16 -1.89
Free Cash Flow 1.32 0.03 -97.56
Revenue 9.52 9.58 0.65
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 2.25 2.35 4.47
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -0.53 -0.57 -7.84
Naive Interpretation Member
06 - Financial Health · Bad
End of CTSH's Analysis
CIK: 1058290 CUSIP: 192446102 ISIN: US1924461023 LEI: - UEI: -
Secondary Listings